BharatBiotech’s Covaxin is now available for children of age 6+

The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between the ages of 6 to 12.

The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between the ages of 6 to 12. Along with Covaxin, Union Health Minister Mansukh Mandaviya announced the approval of Corbevax and ZyCov-D vaccines for children.

This action is taken on the recommendation of the Subject Expert Committee (SEC) on Covid-19 by the Central Drugs Standard Control Organisation or CDSCO. The SEC had last week received applications from BharatBiotech’s Covaxin (for age group 6 to 12) and from Biological E’s Corbevax (for age 5 to 12).

The SEC gave BharatBiotech the no-objection certificate after a two-month-long deliberation on the topic. The DCGI has also asked BharatBiotech to share their safety data and data on adverse events twice every month for 2 months. After these two months, the vaccine maker can monthly send 1 report for 5 consecutive months. 

In December 2021 the DCGI had given Emergency Use Listing (EUL) to Covaxin to be used for ages 12 to 18. Corbevax on the other hand has been used for the age group 12 to 14. Even Zydus Cadila’s two-dose regimen ZycovD vaccine against Covid-19 has been approved for children over the age of 12 years. ZycovD showed a 66.6% efficacy in the interim analysis during Phase 3 clinical trials. 

The vaccination drive started on March 1st for people above the age of 60 years. A month later, on April 1st, the vaccination drive began for people over the age of 45. From May 1st onwards, a vaccination drive for every adult (18 years of age) began. Next came the age group of 15 to 18, for whom the vaccination phase began on January 3rd.

Tags : #BharatBiotech #Covaxin #vaccination #Children-Vaccination #vaccine #Covid-19 #Corbevax #Zycov-D #UnionHealthMinister #MansukhMandaviya #smitakumar #medicircle

About the Author


Priyal Shah

Priyal Shah is a graduate of Media from Mithibai College, Mumbai. She is a writer, researcher and avid reader.

Related Stories

Loading Please wait...

-Advertisements-


Trending Now

Is Liposuction surgery safe? Know the side effects of Liposuction Surgery May 21, 2022
The BD 'Advances in Clinical Flow Cytometry' Event provides clinicians with a rich knowledge-sharing platformMay 21, 2022
Omega 3 fatty acids – The essential fatMay 21, 2022
Vitamin B12 – Deficiency and sourcesMay 21, 2022
CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure.May 20, 2022
Hanuman raises over $.5 million to expand its emergency medical response services in Bihar, Jharkand and UP May 20, 2022
Sudden Infant Death Syndrome (SIDS) – Causes and preventive methodsMay 20, 2022
Healthcare Innovation Challenge: Data's Expanding Role in the Healthcare SectorMay 20, 2022
Homeopathy in Pregnancy - Homeopathy Treatment | MedicircleMay 20, 2022
MetroMedi launches the MetroMedi Relief platform for mental and sexual health wellbeing.May 20, 2022
Top Health Benefits for Butter milk May 20, 2022
Sumit Agarwal- Born with Cerabral Palsy to today being an acclaimed entrepreneur in the public relations industry in IndiaMay 20, 2022
Five eye hospitals in the Tri-city region have been acquired by Dr. Agarwal's Eye Hospital.May 19, 2022
World Family Doctor Day, 2022 – Family doctor makes care easily accessible May 19, 2022
Adani Enterprises will explore the healthcare industry.May 19, 2022
Tips for Weight Loss May 19, 2022
What should be the diet during menopause? May 19, 2022
5 Tips To Get Rid Of Cracked Heels In SummerMay 19, 2022
How is meditation beneficial in reducing low blood pressure?May 18, 2022
Why should we not eat mushrooms because of kidney disease? May 18, 2022